MedTrace Logo

Efficacy and Safety of Melatonin and Clonazepam for IRBD

NCT03255642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-02-21

No results posted yet for this study

Summary

This study aimed to evaluate influence of melatonin or clonazepam treatment on symptom and polysomnographic parameters in patients with idiopathic REM sleep behavior disorder.

Conditions

  • REM Sleep Behavior Disorder

Interventions

DRUG

Melatonin 2mg

4 weeks of 2mg prolonged release melatonin (Circadin)

DRUG

ClonazePAM 0.5 MG

4 weeks of 0.5mg clonazepam (Rivotril)

Sponsors & Collaborators

  • Kyung Hee University Hospital at Gangdong

    lead OTHER

Principal Investigators

  • Won Chul Shin, M.D. Ph.D. · KyungHee University Hospital at Gangdong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-09
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255642 on ClinicalTrials.gov